Skip to main content
Top
Published in: Inflammation 3/2012

01-06-2012

The Effects of the Combination of Sodium Ferulate and Oxymatrine on Lipopolysaccharide-Induced Acute Lung Injury in Mice

Authors: Xiaopei Yuan, Yuyun Wang, Dunren Du, Zhao Hu, Mengxin Xu, Mingbo Xu, Zhifeng Liu

Published in: Inflammation | Issue 3/2012

Login to get access

Abstract

In our previous study, the remarkable analgesic and anti-inflammatory effects of the combination of sodium ferulate (SF) and oxymatrine (OMT) had been found. In this study, we investigated the effect of the combination of SF and OMT on acute lung injury using lipopolysaccharide (LPS)-induced acute lung injury (ALI) mouse model. The cell counting and the protein concentration in the bronchoalveolar lavage fluid (BALF) were measured. The animal lung edema degree was evaluated by wet/dry weight (W/D) ratio. The superoxidase dismutase (SOD) activity and myeloperoxidase (MPO) activity was assayed by SOD and MPO kits, respectively. The levels of inflammatory mediators including C-reactive protein (CRP) and tumor necrosis factor-α (TNF-α) were assayed by enzyme-linked immunosorbent assay method. The data showed that treatment with the combination of SF and OMT markedly attenuated inflammatory cell numbers and protein concentration in the BALF and improved SOD activity and inhibited MPO activity compared to LPS group. Moreover, the combination significantly inhibited the production of CRP and TNF-α in lung homogenate. The histological changes of the lungs were also more significantly improved by the combination. At the same dose, the obvious protective effect was not found in SF or OMT-treated alone group except that the protein concentration slightly decreased in SF group. The results indicated that the combination SF and OMT had a protective effect on LPS-induced ALI in mice, and the effect was much better than that of SF or OMT used alone.
Literature
1.
go back to reference Bersten, A.D., C. Edibam, T. Hunt, and J. Moran. 2002. Incidence andmortality of acute lung injury and the acute respiratory distress syndrome in three Australian states. American Journal of Respiratory and Critical Care Medicine 165: 443–448.PubMed Bersten, A.D., C. Edibam, T. Hunt, and J. Moran. 2002. Incidence andmortality of acute lung injury and the acute respiratory distress syndrome in three Australian states. American Journal of Respiratory and Critical Care Medicine 165: 443–448.PubMed
2.
go back to reference Chau, C.S., N.G. Michelle, Z. Rihong, C. Feng, K. Ednan, and E.K. Bajwa. 2010. Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS. American College of Chest Physicians 138: 559–567. Chau, C.S., N.G. Michelle, Z. Rihong, C. Feng, K. Ednan, and E.K. Bajwa. 2010. Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS. American College of Chest Physicians 138: 559–567.
3.
go back to reference Chen, Z., X. Zhang, X. Chu, X. Zhang, K. Song, Y. Jiang, L. Yu, and X. Deng. 2010. Preventive effects of Valnemulin on Lipopolysaccharide-induced acute lung injury in mice. Inflammation 33: 306–314.PubMedCrossRef Chen, Z., X. Zhang, X. Chu, X. Zhang, K. Song, Y. Jiang, L. Yu, and X. Deng. 2010. Preventive effects of Valnemulin on Lipopolysaccharide-induced acute lung injury in mice. Inflammation 33: 306–314.PubMedCrossRef
4.
go back to reference Chan, M.H., P.K. Chan, J.F. Griffith, and I.H. Chan. 2006. Steroid-induced osteonecrosis in severe acute respiratory syndrome: a retrospective analysis of biochemical markers of bone metabolism and corticosteroid therapy. Pathology 38(3): 229–235.PubMedCrossRef Chan, M.H., P.K. Chan, J.F. Griffith, and I.H. Chan. 2006. Steroid-induced osteonecrosis in severe acute respiratory syndrome: a retrospective analysis of biochemical markers of bone metabolism and corticosteroid therapy. Pathology 38(3): 229–235.PubMedCrossRef
5.
go back to reference Liu, H.Q., Y. Sun, Y. Gao, F.F. Chen, M.B. Xu, and Z.F. Liu. 2010. The analgesic effect and mechanism of the combination of sodium ferulate and oxymatrine. Neurochem Research 35: 1368–1375.CrossRef Liu, H.Q., Y. Sun, Y. Gao, F.F. Chen, M.B. Xu, and Z.F. Liu. 2010. The analgesic effect and mechanism of the combination of sodium ferulate and oxymatrine. Neurochem Research 35: 1368–1375.CrossRef
6.
go back to reference Yuan, X.P., Y. Sun, N.S. Miao, S.Y. Sun, Y.Y. Wang, Z. Hu, and J. Yuan. 2011. The synergistic anti-inflammatory effect of the combination of sodium ferulate and oxymatrine and its modulation on inflammation-associated mediators in RAW 264.7 cells. Journal of Ethnopharmacology 137:1477–1485. Yuan, X.P., Y. Sun, N.S. Miao, S.Y. Sun, Y.Y. Wang, Z. Hu, and J. Yuan. 2011. The synergistic anti-inflammatory effect of the combination of sodium ferulate and oxymatrine and its modulation on inflammation-associated mediators in RAW 264.7 cells. Journal of Ethnopharmacology 137:1477–1485.
7.
go back to reference Itoh, T., H. Obata, S. Murakami, K. Hamada, K. Kangawa, H. Kimura, and N. Nagaya. 2007. Adrenomedullin ameliorates lipopolysaccharide-induced acute lung injury in rats. American Journal of Physiology 293: L446–L452.PubMed Itoh, T., H. Obata, S. Murakami, K. Hamada, K. Kangawa, H. Kimura, and N. Nagaya. 2007. Adrenomedullin ameliorates lipopolysaccharide-induced acute lung injury in rats. American Journal of Physiology 293: L446–L452.PubMed
8.
go back to reference Speyer, C.L., T.A. Neff, R.L. Warner, R.F. Guo, J.V. Sarma, N.C. Riedemann, M.E. Murphy, H.S. Murphy, and P.A. Ward. 2003. Regulatory effects of iNOS on acute lung inflammatory responsesin mice. American Journal of Pathology 163: 2319–2328.PubMedCrossRef Speyer, C.L., T.A. Neff, R.L. Warner, R.F. Guo, J.V. Sarma, N.C. Riedemann, M.E. Murphy, H.S. Murphy, and P.A. Ward. 2003. Regulatory effects of iNOS on acute lung inflammatory responsesin mice. American Journal of Pathology 163: 2319–2328.PubMedCrossRef
9.
go back to reference Kang, J.L., H.W. Lee, H.S. Lee, I.S. Pack, Y. Chong, and V. Castranova. 2001. Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide. American Journal of Respiratory and Critical Care Medicine 164: 2206–2212.PubMed Kang, J.L., H.W. Lee, H.S. Lee, I.S. Pack, Y. Chong, and V. Castranova. 2001. Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide. American Journal of Respiratory and Critical Care Medicine 164: 2206–2212.PubMed
10.
go back to reference Arsalane, K., F. Broeckaert, B. Knoops, M. Wiedig, G. Toubeau, and A. Bernard. 2000. Clara cell specific protein (CC16) expression after acute lung inflammation induced by intratracheal lipopolysaccharide administration. American Journal of Respiratory and Critical Care Medicine 161: 1624–1630.PubMed Arsalane, K., F. Broeckaert, B. Knoops, M. Wiedig, G. Toubeau, and A. Bernard. 2000. Clara cell specific protein (CC16) expression after acute lung inflammation induced by intratracheal lipopolysaccharide administration. American Journal of Respiratory and Critical Care Medicine 161: 1624–1630.PubMed
11.
go back to reference Hong, B.B., W.J. Cheol, L. Mei, S.K. Hyung, and H.K. Sang. 2011. Effects of urinary trypsin inhibitor on lipopolysaccharide-induced acute lung injury in rabbits. Inflammation (online first). Hong, B.B., W.J. Cheol, L. Mei, S.K. Hyung, and H.K. Sang. 2011. Effects of urinary trypsin inhibitor on lipopolysaccharide-induced acute lung injury in rabbits. Inflammation (online first).
12.
go back to reference Matute, B.G., R.K. Winn, M. Jonas, E.Y. Chi, T.R. Martin, and W.C. Liles. 2001. Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: Implications for acute pulmonary inflammation. American Journal of Pathology 158: 153.CrossRef Matute, B.G., R.K. Winn, M. Jonas, E.Y. Chi, T.R. Martin, and W.C. Liles. 2001. Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: Implications for acute pulmonary inflammation. American Journal of Pathology 158: 153.CrossRef
13.
go back to reference Wang, B.H., and J.P. Ou-Yang. 2005. Pharmacological actions of sodium ferulate in cardiovascular system. Cardiovascular Drug Review 23: 161–172.CrossRef Wang, B.H., and J.P. Ou-Yang. 2005. Pharmacological actions of sodium ferulate in cardiovascular system. Cardiovascular Drug Review 23: 161–172.CrossRef
14.
go back to reference Xu, G.L., L. Yao, S.Y. Rao, Z.N. Gong, S.Q. Zhang, and S.Q. Yu. 2005. Attenuation of acute lung injury in mice by oxymatrine is associated with inhibition of phosphorylated p38 mitogen-activated protein kinase. Journal of Ethnopharmacology 98: 177–183.PubMedCrossRef Xu, G.L., L. Yao, S.Y. Rao, Z.N. Gong, S.Q. Zhang, and S.Q. Yu. 2005. Attenuation of acute lung injury in mice by oxymatrine is associated with inhibition of phosphorylated p38 mitogen-activated protein kinase. Journal of Ethnopharmacology 98: 177–183.PubMedCrossRef
15.
go back to reference Szarka, R.J., N. Wang, L. Gordon, P.N. Nation, and R.H. Smith. 1997. A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation. Journal of Immunological Methods 202: 49–57.PubMedCrossRef Szarka, R.J., N. Wang, L. Gordon, P.N. Nation, and R.H. Smith. 1997. A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation. Journal of Immunological Methods 202: 49–57.PubMedCrossRef
16.
go back to reference Xu, X.L., Q.M. Xie, Y.H. Shen, J.J. Jiang, Y.Y. Chen, H.Y. Yao, and J.Y. Zhou. 2008. Mannose prevents lipopolysaccharide-induced acute lung injury in rats. Inflammation Research 57: 104–110.PubMedCrossRef Xu, X.L., Q.M. Xie, Y.H. Shen, J.J. Jiang, Y.Y. Chen, H.Y. Yao, and J.Y. Zhou. 2008. Mannose prevents lipopolysaccharide-induced acute lung injury in rats. Inflammation Research 57: 104–110.PubMedCrossRef
17.
18.
go back to reference Winterbourn, C.C., M.C. Vissers, and A.J. Kettle. 2000. Myeloperoxidase. Current Opinion in Hematology 7: 53–58.PubMedCrossRef Winterbourn, C.C., M.C. Vissers, and A.J. Kettle. 2000. Myeloperoxidase. Current Opinion in Hematology 7: 53–58.PubMedCrossRef
19.
go back to reference Meduri, G.U., S. Headley, G. Kohler, et al. 1995. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. The Cardiopulmonary and Critical Care Journal 107: 1062–1073. Meduri, G.U., S. Headley, G. Kohler, et al. 1995. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. The Cardiopulmonary and Critical Care Journal 107: 1062–1073.
20.
go back to reference Ballou, S.P., and G. Lozanski. 1992. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 4: 361–368.PubMedCrossRef Ballou, S.P., and G. Lozanski. 1992. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 4: 361–368.PubMedCrossRef
21.
go back to reference Cermak, J., N.S. Key, R.R. Bach, J. Balla, H.S. Jacob, and G.M. Vercellotti. 1993. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82: 513–520.PubMed Cermak, J., N.S. Key, R.R. Bach, J. Balla, H.S. Jacob, and G.M. Vercellotti. 1993. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82: 513–520.PubMed
Metadata
Title
The Effects of the Combination of Sodium Ferulate and Oxymatrine on Lipopolysaccharide-Induced Acute Lung Injury in Mice
Authors
Xiaopei Yuan
Yuyun Wang
Dunren Du
Zhao Hu
Mengxin Xu
Mingbo Xu
Zhifeng Liu
Publication date
01-06-2012
Publisher
Springer US
Published in
Inflammation / Issue 3/2012
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-011-9424-3

Other articles of this Issue 3/2012

Inflammation 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine